POLE and colorectal carcinoma: POLE c.861T>A (p.Asp287Glu) (MAFgnomAD_NFE = 0.17%) was identified in two unrelated breast cancer patients, one of whom was also diagnosed with an MMR-deficient CRC (Table 1).